Malaria in Pregnancy (MiP) Resources

Publish Date: January 2018
Author: MCSP

Each year, malaria in pregnancy (MiP) is responsible for 20% of stillbirths and 11% of newborn deaths in sub-Saharan Africa. MCSP is committed to providing resources and technical assistance to strengthen MIP programs to deliver health impact.

In 2016, WHO released Recommendations on Antenatal Care for a Positive Pregnancy Experience. These ANC recommendations should be adapted to each country’s context, and should be applied flexibly so that pregnant women always receive intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine (IPTp-SP) when eligible, starting as early as possible during the second trimester of pregnancy.

MCSP, in collaboration with PMI and the Roll Back Malaria MiP Working Group, has developed a series of resources and tools to help policy makers, program implementers, and clinicians design and deliver high quality MIP interventions in the context of the 2016 WHO recommendations. MCSP invites feedback on any of these tools and resources, and encourages stakeholders to share them broadly.

Malaria in Pregnancy Resources:

*Implementing in the context of the Recommendations on Antenatal Care for a Positive Pregnancy Experience (WHO, 2016)

Malaria in Pregnancy tools to support program implementation: